Eupraxia Pharmaceuticals (EPRX) Preferred Shares (2024 - 2025)
Eupraxia Pharmaceuticals (EPRX) reported Preferred Shares of $29.74 million for the quarter ended Dec 31, 2025, down 6.2% from $31.71 million a year earlier.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Preferred Shares (2024 - 2025) Analysis & Trends
- By year, Preferred Shares came in at $31.71 million in the year ended Dec 31, 2024 (unchanged) and $31.71 million in the year ended Dec 31, 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Eupraxia Pharmaceuticals | 308.46 Mn | -133.60 Mn | - | - |
API Access
Eupraxia Pharmaceuticals Preferred Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-shares&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-shares", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=preferred-shares&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();